Inventor · disambiguated record
Jiansheng Wan
Also filed as: WAN JIANSHENG
14 granted patents·22 pending applications·628 citations·filing 1991–2025
92Inventor score
Top patents by PatentIndex Score
36 records- 0198US6929803B2Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatingsALZA CORP·Filed 2002·Granted Aug 16, 2005·143 cites·20 claims
- 0298US6419952B2Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatingsALZA CORP·Filed 2001·Granted Jul 16, 2002·129 cites·20 claims
- 0397US5254342ACompositions and methods for enhanced transepithelial and transendothelial transport or active agentsUNIV SOUTHERN CALIFORNIA·Filed 1991·Granted Oct 19, 1993·335 cites·2 claims
- 0483US8945620B2Solid pharmaceutical compositions containing pregabalinWARNER LAMBERT CO·Filed 2014·Granted Feb 3, 2015·5 cites·17 claims
- 0581US10022447B2Solid pharmaceutical compositions containing pregabalinWARNER LAMBERT CO·Filed 2017·Granted Jul 17, 2018·2 cites·8 claims
- 0681US9101615B2Intravenous formulations of neurokinin-1 antagonistsWAN JIANSHENG·Filed 2010·Granted Aug 11, 2015·10 cites·44 claims
- 0776US10940135B2Paclitaxel pharmaceutical composition and pharmaceutical preparation thereof, preparation process and use thereofSINOTHERAPEUTICS INC·Filed 2017·Granted Mar 9, 2021·1 cites·9 claims
- 0873US9144559B2Solid pharmaceutical compositions containing pregabalinWARNER LAMBERT CO·Filed 2014·Granted Sep 29, 2015·1 cites·6 claims
- 0970US10022373B2Posaconazole pharmaceutical compositions and preparation methods, uses and pharmaceutical formulations thereofSINOTHERAPEUTICS INC·Filed 2015·Granted Jul 17, 2018·2 cites·13 claims
- 1069US11034673B2(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparationsMERCK SHARP & DOHME·Filed 2020·Granted Jun 15, 2021·0 cites·1 claims
- 1165US10710982B2(S)-N-(3-6-isopropoxypyridin-3-3YL)-1H-indazol-5-yl)-1-(2-(4-4(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H-yl)-2-oxoethyl)-3(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparationsMERCK SHARP & DOHME·Filed 2020·Granted Jul 14, 2020·0 cites·3 claims
- 1262US12453737B2Method for hydrating lyophilized cyclophosphamide composition and product thereofSINOTHERAPEUTICS INC·Filed 2019·Granted Oct 28, 2025·0 cites·18 claims
- 1362US2013303618A1Solid Pharmaceutical Compositions Containing PregabalinWARNER LAMBERT CO·Filed 2013·Application pending·0 cites
- 1461US2013102675A1Solid Pharmaceutical Compositions Containing PregabalinWARNER LAMBERT CO·Filed 2012·Application pending·0 cites
- 1561US2007269511A1Solid pharmaceutical compositions containing pregabalinWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 1660US2025312363A1Method for hydrating lyophilized cyclophosphamide composition and product thereofSINOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1760US2011034478A1Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAsSCHERING PLOUGH CORP·Filed 2009·Application pending·0 cites
- 1859US2017136125A1Solid Pharmaceutical Compositions Containing PregabalinWARNER-LAMBERT COMPANY LLC·Filed 2017·Application pending·0 cites
- 1958US2025000801A1Darolutamide pharmaceutical composition, preparation method therefor and use thereofSINOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2058US2012232149A1Solid pharmaceutical compositions containing pregabalinBOCKBRADER HOWARD N·Filed 2012·Application pending·0 cites
- 2158US2010081672A1Ph sensitive matrix formulationSCHERING CORP·Filed 2007·Application pending·0 cites
- 2258US2015352066A1Solid Pharmaceutical Compositions Containing PregabalinWARNER LAMBERT CO·Filed 2015·Application pending·0 cites
- 2357US2016250147A1Solid Pharmaceutical Compositions Containing PregabalinWARNER-LAMBERT COMPANY LLC·Filed 2016·Application pending·0 cites
- 2456US2012029081A1Solid Pharmaceutical Compositions Containing PregabalinBOCKBRADER HOWARD N·Filed 2011·Application pending·0 cites
- 2554US2007237818A1Controlled-release formulation of HCV protease inhibitor and methods using the sameMALCOLM BRUCE A·Filed 2006·Application pending·0 cites
- 2653US2011123627A1High density compositions containing posaconazole and formulations comprising the sameFANG LARRY YUN·Filed 2009·Application pending·0 cites
- 2751US2023025316A1Olaparib pharmaceutical composition, formulation thereof, preparation method thereof and use thereofSINOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2849US2015150990A1ORAL PHARMACEUTICAL COMPOSITIONS IN A SOLID DISPERSION COMPRISING PREFERABLY POSACONAZOLE AND HPMCAsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2948US2023055404A1Solid preparation, and preparation method therefor and use thereofSINOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3047US2009280160A1Phenylephrine pharmaceutical formulations and compositions for transmucosal absorptionSCHERING PLOUGH HEALTHCARE·Filed 2008·Application pending·0 cites
- 3145US2012022032A1Corticosteroid compositions and methods of treatments thereofWAN JIANSHENG·Filed 2009·Application pending·0 cites
- 3244US2015290147A1Phenylephrine pharmaceutical formulations and compositions for colonic abosorptionMSD CONSUMER CARE INC·Filed 2014·Application pending·0 cites
- 3344US2020155579A1Process for Hydrating Cyclophosphamide Freeze-Dried Composition and Product ThereofSINOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3442US10391103B2Ferroporphyrin solid dispersion and preparation method thereofSINOTHERAPEUTICS INC·Filed 2014·Granted Aug 27, 2019·0 cites·23 claims
- 3540US2016024092A1Intravenous formulations of neurokinin-1 antagonistsOPKO HEALTH INC·Filed 2015·Application pending·0 cites
- 3639US8956662B2Phenylephrine pharmaceutical formulations and compositions for colonic absorptionMONTEITH DAVID·Filed 2007·Granted Feb 17, 2015·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →